Ophthalmology · North Hollywood, CA
NPI
1528080694
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4418 Vineland Ave, #106
North Hollywood, CA, 91602
Phone (818) 762-0647
Groups this clinician bills Medicare through
Medicare paid, 2024
$207K
2,470 services
Medicare patients, 2024
619
Average age 76
Drug cost, 2024
$592K
2,860 prescriptions
Company payments, 2025
$651
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dana P Tannenbaum was code 92133 (computerized ophthalmic imaging), 502 times for 383 patients. In total Dana P Tannenbaum billed 2,470 services in 46 codes, and Medicare paid $207K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92133 Computerized Ophthalmic Imaging | Office | 502 | 383 | $27.17 | $14K |
| 92012 Ophthalmological E&M | Office | 432 | 317 | $67.76 | $29K |
| 92014 Ophthalmological E&M | Office | 426 | 414 | $89.38 | $38K |
| 92083 Vision, Hearing, and Speech Services | Office | 226 | 220 | $46.89 | $11K |
| 92136 Ultrasound - Nonspecific | Office | 140 | 65 | $21.21 | $2,970 |
| 66984 Cataract Surgery | Facility | 104 | 65 | $420.45 | $44K |
| 92250 Angiography | Office | 98 | 97 | $28.91 | $2,834 |
| 92020 Ophthalmological E&M | Office | 73 | 72 | $20.93 | $1,528 |
| 66821 Cataract Surgery | Office | 61 | 48 | $279.58 | $17K |
| 99204 Office E&M - New | Office | 60 | 60 | $113.32 | $6,799 |
| 68761 Eye | Office | 55 | 39 | $165.52 | $9,104 |
| 76514 Ultrasound - Nonspecific | Office | 55 | 55 | $8.25 | $454 |
| 83861 Clinical Chemistry | Office | 48 | 23 | $21.11 | $1,013 |
| 76519 Ultrasound - Nonspecific | Office | 31 | 14 | $29.72 | $921 |
| 92004 Ophthalmological E&M | Office | 21 | 21 | $110.29 | $2,316 |
By year: 2022 $212K for 2,534 services; 2023 $219K for 2,699 services; 2024 $207K for 2,470 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 48 | 23 | $21.11 | $1,013 |
Medicare prescription drug claims, 2024
In 2024, the drug Dana P Tannenbaum prescribed most often to Medicare patients was Latanoprost, with 529 prescriptions and refills. In total Dana P Tannenbaum wrote 2,860 Medicare prescriptions that cost $592K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 529 | 935 | 126 | $4,737 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 207 | 447 | 61 | $3,780 |
| Timolol Maleate Generic | 194 | 385 | 59 | $3,149 |
| Lumigan Bimatoprost | 174 | 307 | 44 | $80K |
| Brimonidine Tartrate Generic | 128 | 203 | 32 | $8,178 |
| Travoprost Generic | 111 | 206 | 26 | $28K |
| Tafluprost Tafluprost/Pf | 97 | 176 | 23 | $21K |
| Vyzulta Latanoprostene Bunod | 93 | 143 | 19 | $39K |
| Besivance Besifloxacin Hcl | 81 | 87 | 50 | $18K |
| Rocklatan Netarsudil Mesylat/Latanoprost | 81 | 117 | 17 | $41K |
| Prednisolone Acetate Generic | 76 | 121 | 51 | $3,318 |
| Restasis Cyclosporine | 75 | 95 | 13 | $59K |
| Dorzolamide Hcl Generic | 74 | 129 | 27 | $981 |
| Combigan Brimonidine Tartrate/Timolol | 70 | 127 | 21 | $29K |
| Prolensa Bromfenac Sodium | 64 | 91 | 44 | $23K |
Brand drugs: 1,576 claims; generic drugs: 1,284 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dana P Tannenbaum $651 ($651 in general payments such as food, travel and fees) from 4 companies. The largest payer was Glaukos Corporation with $264.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.